Salomonsson Emelie, Kuoppa Kerstin, Forslund Anna-Lena, Zingmark Carl, Golovliov Igor, Sjöstedt Anders, Noppa Laila, Forsberg Ake
FOI Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, Sweden.
Infect Immun. 2009 Aug;77(8):3424-31. doi: 10.1128/IAI.00196-09. Epub 2009 Jun 8.
A disadvantage of several old vaccines is that the genetic events resulting in the attenuation are often largely unknown and reversion to virulence cannot be excluded. In the 1950s, a live vaccine strain, LVS, was developed from a type B strain of Francisella tularensis, the causative agent of tularemia. LVS, which is highly attenuated for humans but still virulent for mice by some infection routes, has been extensively studied and found to protect staff from laboratory-acquired tularemia. The efforts to improve biopreparedness have identified a demand for a vaccine against tularemia. Recently the rapid progress in genomics of different Francisella strains has led to identification of several regions of differences (RDs). Two genes carried within RDs, pilA, encoding a putative type IV pilin, and FTT0918, encoding an outer membrane protein, have been linked to virulence. Interestingly, LVS has lost these two genes via direct repeat-mediated deletions. Here we show that reintroduction of the two deleted regions restores virulence of LVS in a mouse infection model to a level indistinguishable from that of virulent type B strains. The identification of the two attenuating deletion events could facilitate the licensing of LVS for use in humans.
几种旧疫苗的一个缺点是,导致减毒的基因事件往往很大程度上不为人知,且无法排除恢复毒力的可能性。在20世纪50年代,一种活疫苗株LVS从土拉弗朗西斯菌B型菌株(兔热病的病原体)中研发出来。LVS对人类高度减毒,但通过某些感染途径对小鼠仍具毒性,已得到广泛研究,并发现其能保护工作人员免受实验室获得性兔热病感染。提高生物防范能力的努力确定了对兔热病疫苗的需求。最近,不同弗朗西斯菌菌株基因组学的快速进展导致了几个差异区域(RDs)的鉴定。RDs中携带的两个基因,编码假定IV型菌毛蛋白的pilA和编码外膜蛋白的FTT0918,已与毒力相关联。有趣的是,LVS通过直接重复介导的缺失失去了这两个基因。在此我们表明,重新引入这两个缺失区域可使LVS在小鼠感染模型中的毒力恢复到与强毒株B型菌株无法区分的水平。这两个减毒缺失事件的鉴定可能有助于LVS获得用于人类的许可。